Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $6.10 $80.02 Wednesday, 8th May 2024 CLNN stock ended at $0.390. This is 0.383% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 6.14% from a day low at $0.370 to a day high of $0.393.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Clene Inc. prices

Date Open High Low Close Volume
Oct 03, 2023 $0.493 $0.500 $0.431 $0.447 317 829
Oct 02, 2023 $0.524 $0.524 $0.453 $0.489 243 265
Sep 29, 2023 $0.513 $0.530 $0.480 $0.496 234 437
Sep 28, 2023 $0.520 $0.540 $0.495 $0.500 344 590
Sep 27, 2023 $0.520 $0.550 $0.515 $0.528 532 587
Sep 26, 2023 $0.464 $0.610 $0.464 $0.525 1 643 266
Sep 25, 2023 $0.484 $0.530 $0.415 $0.464 1 139 833
Sep 22, 2023 $0.531 $0.531 $0.463 $0.463 308 554
Sep 21, 2023 $0.506 $0.513 $0.461 $0.481 331 045
Sep 20, 2023 $0.500 $0.540 $0.482 $0.482 842 415
Sep 19, 2023 $0.540 $0.540 $0.476 $0.488 768 532
Sep 18, 2023 $0.579 $0.580 $0.530 $0.540 278 837
Sep 15, 2023 $0.573 $0.600 $0.523 $0.540 1 490 447
Sep 14, 2023 $0.630 $0.640 $0.590 $0.599 435 003
Sep 13, 2023 $0.640 $0.657 $0.600 $0.607 463 797
Sep 12, 2023 $0.665 $0.675 $0.630 $0.631 311 030
Sep 11, 2023 $0.700 $0.700 $0.650 $0.656 427 260
Sep 08, 2023 $0.676 $0.680 $0.645 $0.650 129 048
Sep 07, 2023 $0.698 $0.703 $0.644 $0.659 301 671
Sep 06, 2023 $0.711 $0.734 $0.670 $0.698 204 360
Sep 05, 2023 $0.740 $0.779 $0.690 $0.718 389 449
Sep 01, 2023 $0.756 $0.760 $0.729 $0.731 217 314
Aug 31, 2023 $0.770 $0.770 $0.710 $0.720 248 645
Aug 30, 2023 $0.710 $0.770 $0.705 $0.761 301 370
Aug 29, 2023 $0.740 $0.740 $0.690 $0.705 610 060
Click to get the best stock tips daily for free!

About Clene Inc.

Clene. Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; com... CLNN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT